Linnaeus Therapeutics, Inc.

New Filing
CIK: 0001752026·Biotechnology·DELAWARE·Filed: Sep 7, 2018
Total Offering

Indefinite

Amount Sold

$2,160,000

Investors

4

First Sale

Aug 27, 2018

Offering Details

Type
Equity
Exemptions
Rule 506(b), Section 4(a)(5)
Entity Type
Corporation
Year Incorporated
2015
Non-Accredited Investors
No

Related Persons

NameRole
Patrick T. Mooney
Related Person
Michael D. Poisel
Related Person
Christopher Natale
Related Person
Nicholas Iatropoulos
Related Person

Company

Linnaeus Therapeutics, Inc.

30 Washington Avenue, Suite F

Haddonfield, NJ, 08033

(856) 433-1500

SEC Filing

0001752026-18-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Linnaeus Therapeutics, Inc. Form D Filing — Indefinite | FilingFlow